Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts.
Journal: HemaSphere
Published: January 12, 2026
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia.
Journal: HemaSphere
Published: October 02, 2024
Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine-induced adverse effects in an acute lymphoblastic leukemia patient-derived xenograft model.
Journal: HemaSphere
Published: August 08, 2024
MiRNAs from the Dlk1-Dio3 locus and miR-224/452 cluster contribute to glioblastoma tumor heterogeneity.
Journal: Scientific reports
Published: October 30, 2023
In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenografts.
Journal: Experimental hematology
Published: October 25, 2023
In vivo activity of the dual SYK/FLT3 inhibitor TAK-659 against pediatric acute lymphoblastic leukemia xenografts.
Journal: Pediatric blood & cancer
Published: March 01, 2023
In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts.
Journal: Pediatric blood & cancer
Published: September 16, 2022
An evaluation of strategies to achieve greater than 90% coverage of maternal influenza and pertussis vaccines including an economic evaluation.
Journal: BMC pregnancy and childbirth
Published: June 13, 2021
Cataloguing the small RNA content of honey using next generation sequencing.
Journal: Food chemistry. Molecular sciences
Published: October 21, 2020
Last Updated: 09/26/2026